Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 04 March 2021


We are all on #TeamVaccines | Video




Maintaining the exchange of critical health data
03 March 2021

An adequacy decision on the UK data protection regime Read more

EU Structured Dialogue on Supply Chain Security: evidence, partnership and global resilience...
01 March 2021

To remain competitive, Europe needs longer-term investment, incentives and global regulatory harmonisation Read more


From our blog


Learnings from COVID-19: Partnerships leading the way for clinical trial modernisation (Guest...
03 March 2021 - Annette Bakker

Platform trials would prove especially helpful in rare disease research. Since these illnesses affect small to very... Read more

A formula for vaccine breakthroughs
01 March 2021 - Nathalie Moll

Intellectual property is a key ingredient in COVID-19 vaccine development Read more

Bringing new cancer treatments to European patients: The challenge of making it across all...
01 March 2021 - Baz Amesz

Let’s take a look at the overall picture of bringing new cancer treatments to European patients across all three access... Read more


19 Conversations | Catch up with the latest EFPIA podcasts




Immunology Virtual Partnering
09 March 2021 (Virtual event)

Autoimmune and Inflammatory Disease: During four days of face-to-face online meetings, leading researchers, top biotechs... Read more

Innovation for Health
15 April 2021 (Hybrid event)

On 15-16 April 2021, the 8th edition of Innovation for Health takes place as a hybrid edition. Read more


What we are reading


Case Study: An integrated initiative to optimize future obesity treatment
On 04 March 2021 (European Partnership for Health Innovation)

A multi-sectoral public-private partnership to maintain Europe at the forefront of medical innovation for the benefit... Read more

Blueprint for Action on Diabetes in the European Union by 2030
On 26 February 2021 (MEPs Mobilising for Diabetes)

The Blueprint is the cornerstone of the activities of MEPs Mobilising for Diabetes and is also a critical tool for everyone,... Read more

New principles on incentivizing antibiotic R&D
On 25 February 2021 (IFPMA)

Antibiotics have transformed healthcare. But today, the ubiquitous use of these live-saving drugs has led to the development... Read more